search
Back to results

Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure (Boussignac)

Primary Purpose

Acute-on-chronic Respiratory Failure

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
non- invasive ventilation
Sponsored by
Vygon GmbH & Co. KG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute-on-chronic Respiratory Failure focused on measuring non-invasion ventilation, Boussignac

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 7,25 ≤ pH ≤ 7,35
  • PaCO2 ≥ 45 mmHg

Exclusion Criteria:

  • pH < 7,24
  • incapable of collaboration

Sites / Locations

  • RoMed Klinikum Rosenheim

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

non-invasive ventilation

Arm Description

Outcomes

Primary Outcome Measures

Sinking pCO2

Secondary Outcome Measures

Full Information

First Posted
February 7, 2013
Last Updated
February 7, 2013
Sponsor
Vygon GmbH & Co. KG
search

1. Study Identification

Unique Protocol Identification Number
NCT01788345
Brief Title
Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure
Acronym
Boussignac
Official Title
Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure
Study Type
Interventional

2. Study Status

Record Verification Date
February 2013
Overall Recruitment Status
Unknown status
Study Start Date
February 2013 (undefined)
Primary Completion Date
August 2013 (Anticipated)
Study Completion Date
December 2013 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vygon GmbH & Co. KG

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether the new Boussignac-system of non-invasive ventilation is as good as the conventional non-invasive System in patients presenting with acute hypercapnic respiratory failure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute-on-chronic Respiratory Failure
Keywords
non-invasion ventilation, Boussignac

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
44 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
non-invasive ventilation
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
non- invasive ventilation
Other Intervention Name(s)
Boussignac
Intervention Description
non-invasive bi-level ventilation with IPAP and EPAP.
Primary Outcome Measure Information:
Title
Sinking pCO2
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 7,25 ≤ pH ≤ 7,35 PaCO2 ≥ 45 mmHg Exclusion Criteria: pH < 7,24 incapable of collaboration
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stephan Budweiser, PD
Official's Role
Study Director
Facility Information:
Facility Name
RoMed Klinikum Rosenheim
City
Rosenheim
State/Province
Bavarian
ZIP/Postal Code
83022
Country
Germany

12. IPD Sharing Statement

Links:
URL
http://www.cebp.nl/vault_public/filesystem
Description
Boussignac, non-invasive ventilation

Learn more about this trial

Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure

We'll reach out to this number within 24 hrs